Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals RSUs by Year
RSUs — Weighted-average grant-date fair value of nonvested shares ($/sh) ($)
Vertex Pharmaceuticals RSUs: $431 in FY2025, up 15.8% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Stock-based Compensation — RSU Rollforward).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | RSUs — Weighted-average grant-date fair value of nonvested shares ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 431 | +15.8% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 373 | +29.6% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 287 | +19.5% | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 241 | +12.8% | Form 10-K (filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 213 | +3.0% | Form 10-K (filed 2023-02-10) ↗ |
| FY2020 | Dec 31, 2020 | 207 | +26.5% | Form 10-K (filed 2022-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 164 | +16.8% | Form 10-K (filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 140 | +28.2% | Form 10-K (filed 2020-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 109 | +18.0% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 92.62 | -5.8% | Form 10-K (filed 2018-02-15) ↗ |
| FY2015 | Dec 31, 2015 | 98.36 | – | Form 10-K (filed 2017-02-23) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals RSUs ($), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rsu-nonvested-wafv
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.